Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: Comparison with MR perfusion imaging

American Journal of Neuroradiology

Volumn 30, Issue 7, 2009, Pages 1402-1408

  Park, M J ^a   Kim, Ho Sung ^a   Jahng, G H ^b   Ryu, C W ^b   Park, S M ^a   Kim, S Y ^a  

^a Ajou University School of Medicine   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GLIOBLASTOMA; GLIOMA; HIGH RESOLUTION SUSCEPTIBILITY WEIGHTED IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGING SYSTEM; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALGORITHMS; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PERFUSION IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 68549135204     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1593     Document Type: Article

References (18)

1. Reichenbach JR, Jonetz-Mentzel L, Fitzek C, et al. High-resolution blood oxygen- level dependent MR venography (HRBV): a new technique. Neuroradiology 2001;43:364-369 (Pubitemid 32452070)
2. Reichenbach JR, Essig M, Haacke EM, et al. High-resolution venography of the brain using magnetic resonance imaging. MAGMA 1998;6:62-69 (Pubitemid 28500270)
3. Reichenbach JR, Haacke EM. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed 2001;14:453-467
4. Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005;22:439-450 (Pubitemid 41416402)
5. Lee BC, Vo KD, Kido DK, et al. MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. AJNR Am J Neuroradiol 1999;20:1239-1242
6. de Souza JM, Domingues RC, Cruz LC Jr, et al. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with T2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol 2008;29:154-158
7. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004;25:214-221 (Pubitemid 38235298)
8. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989-1998 (Pubitemid 37444849)
9. Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746-755 (Pubitemid 38657655)
10. Mittal S, Wu Z, Neelavalli J, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009;30:232-252 Epub 2009 Jan 8
11. Pinker K, Noebauer-Huhmann IM, Stavrou I, et al. High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings. AJNR Am J Neuroradiol 2007;28:1280-1286 (Pubitemid 47309659)
12. Barth M, Nobauer-Huhmann IM, Reichenbach JR, et al. High-resolution three-dimensional contrast-enhanced blood oxygenation level-dependent magnetic resonance venography of brain tumors at 3 Tesla: first clinical experience and comparison with 1.5 Tesla. Invest Radiol 2003;38:409-414 (Pubitemid 36791334)
13. Daumas-Duport C, Beuvon F, Varlet P, et al. Gliomas: WHO and Sainte-Anne Hospital classifications. Ann Pathol 2000;20:413-428 (Pubitemid 30839895)
14. Haacke EM, Xu Y, Cheng YC, et al. Susceptibility-weighted imaging (SWI). Magn Reson Med 2004;52:612-618
15. Rauscher A, Sedlacik J, Barth M, et al. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005;26:736-742 (Pubitemid 43079761)
16. Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797-803 (Pubitemid 34919816)
17. Pinker K, Noebauer-Huhmann IM, Stavrou I, et al. High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors. Neuroradiology 2008;50:9-16
18. Covarrubias DJ, Rosen BR, Lev MH. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 2004;9:528-537 (Pubitemid 39332316)